TARDBP and amyotrophic lateral sclerosis: Therefore, in both sporadic and C9orf72 mutation-associated ALS, therapy directed toward TDP-43 neuronal dysmetabolism, causing neuronal cytoplasmic inclusions, is likely to be critically important [14].